News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
256,683 Results
Type
Article (13745)
Company Profile (256)
Press Release (242682)
Section
Business (79209)
Career Advice (147)
Deals (13180)
Drug Delivery (29)
Drug Development (50175)
Employer Resources (31)
FDA (5640)
Job Trends (5110)
News (143705)
Policy (10027)
Tag
Academia (902)
Africa (145)
Allergies (30)
Alliances (21427)
Alzheimer's disease (685)
Antibody-drug conjugate (ADC) (31)
Approvals (5605)
Arizona (38)
Artificial intelligence (31)
Asia (16661)
Australia (2787)
Bankruptcy (96)
Best Places to Work (4353)
Biotechnology (214)
C2C Services and Suppliers (10624)
California (1228)
Canada (500)
Cancer (302)
Career advice (128)
CAR-T (33)
Cell therapy (95)
China (91)
Clinical research (39072)
Collaboration (85)
Colorado (39)
Compensation (40)
Connecticut (42)
COVID-19 (979)
Cystic fibrosis (58)
Data (227)
Diabetes (38)
Diagnostics (1162)
Earnings (28362)
Employer resources (29)
Europe (35780)
Events (45810)
Executive appointments (99)
FDA (5756)
Florida (122)
Funding (98)
Gene editing (28)
Gene therapy (81)
GLP-1 (263)
Government (1053)
Healthcare (6526)
Hotbed/Location (184264)
Illinois (75)
Indiana (43)
Infectious disease (989)
Inflammatory bowel disease (79)
IPO (7137)
Job creations (857)
Job search strategy (124)
Kansas (52)
Layoffs (177)
Legal (1371)
Lung cancer (70)
Manufacturing (29)
Maryland (185)
Massachusetts (995)
Medical device (2517)
Medtech (2518)
Mergers & acquisitions (6049)
Metabolic disorders (132)
Michigan (38)
Minnesota (65)
Neuroscience (793)
New Jersey (331)
New York (397)
NextGen Class of 2024 (1976)
Non-profit (838)
North Carolina (326)
Northern California (535)
Obesity (76)
Ohio (62)
Opinion (87)
Parkinson's disease (31)
Patents (36)
Pennsylvania (276)
People (24729)
Pharmaceutical (41)
Phase I (13700)
Phase II (18169)
Phase III (11566)
Pipeline (77)
Postmarket research (843)
Preclinical (5767)
Press Release (30)
Rare diseases (102)
Real estate (1407)
Regulatory (8031)
Research institute (929)
South America (207)
Southern California (508)
Startups (1964)
Texas (114)
United States (4688)
Vaccines (132)
Washington State (154)
Weight loss (59)
Date
Today (57)
Last 7 days (387)
Last 30 days (1393)
Last 365 days (21463)
2024 (15115)
2023 (22429)
2022 (26842)
2021 (27834)
2020 (23378)
2019 (16256)
2018 (11769)
2017 (13772)
2016 (11853)
2015 (14367)
2014 (10406)
2013 (7500)
2012 (7541)
2011 (7629)
2010 (7432)
256,683 Results for "ait therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Stallergenes Greer Publishes in the Lancet Regional Health-Europe Landmark EfficAPSI Real-world Study Confirming Significant Benefit of Its Liquid Sublingual AIT on the Onset and Progression of Allergic Asthma
Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy, announced that results of its EfficAPSI real-world study evaluating the impact of Stallergenes Greer liquid sublingual AIT on asthma onset and evolution in patients with allergic rhinitis have been published in the Lancet Regional Health-Europe.
May 2, 2024
·
9 min read
Drug Development
AI Therapeutics Announces Positive Results from Phase 2a Biomarker-driven Trial of AIT-101 in Patients with C9ORF72 Amyotrophic Lateral Sclerosis (ALS)
AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today positive results from a Phase 2a clinical trial of AIT-101 (LAM-002A)1 in patients with C9ORF72 amyotrophic lateral sclerosis (ALS)2.
April 5, 2023
·
4 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
NeuroEM Therapeutics(R) Accepted into StartUp Health’s Alzheimer’s Moonshot Community(TM)
September 19, 2024
·
4 min read
Drug Development
Stallergenes Greer Announces Publication of Positive Results for PALFORZIA® Phase 3 Study in Peanut-allergic Children Aged 1 to 3 Years
Stallergenes Greer, a leading global healthcare company specialising in allergen immunotherapy (AIT), announces the publication of results from the Phase 3 POSEIDON (Peanut Oral Immunotherapy Study of Early Intervention for Desensitization) study in the New England Journal of Medicine Evidence.
November 20, 2023
·
6 min read
Pharm Country
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
Aquestive Therapeutics, Inc. announced that the Aquestive management team will participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism and host investor meetings on July 9, 2024.
June 27, 2024
·
2 min read
Business
OrphAI Therapeutics Announces Appointment of Jay Fine to Board of Directors
OrphAI Therapeutics Inc. announced the appointment of Jay S. Fine, Ph.D. to its Board of Directors.
January 24, 2024
·
2 min read
Biotech Beach
Calibre Scientific Expands European Presence and Chromatography Offering With AIT France Acquisition
Calibre Scientific is pleased to announce the acquisition of AIT France, a manufacturer and distributor of innovative consumables for analytical chemistry and chromatography.
January 25, 2021
·
1 min read
Press Releases
Achilles Therapeutics Announces Strategic Update
September 19, 2024
·
6 min read
Genetown
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
Inhibikase Therapeutics, Inc. today announced expansion of its therapeutic pipeline and multiple updates to its Research and Development programs.
June 5, 2024
·
6 min read
1 of 25,669
Next